rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2002-5-1
|
pubmed:abstractText |
Previously, we have reported the development of a new quantitative-competitive polymerase chain reaction (qc-PCR) method to evaluate interferon-beta (IFNbeta) bioavailability in multiple sclerosis (MS) patients, by measuring mRNA of mixovirus resistance protein A (MxA). Here we show that our assay is also able to assess IFNalpha bioavailability in hepatitis C virus (HCV) patients treated with different IFNalpha regimens. Indeed, our method was able to detect a slight constitutive expression of MxA mRNA in untreated HCV patients (median=70 fgMxA/pgGAPDH) and a significant induction 12 h after the first IFNalpha administration (median=750 fgMxA/pgGAPDH).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-1759
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
262
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
187-90
|
pubmed:dateRevised |
2005-5-27
|
pubmed:meshHeading |
pubmed-meshheading:11983232-Antiviral Agents,
pubmed-meshheading:11983232-Biological Availability,
pubmed-meshheading:11983232-GTP-Binding Proteins,
pubmed-meshheading:11983232-Hepatitis C,
pubmed-meshheading:11983232-Humans,
pubmed-meshheading:11983232-Interferon-alpha,
pubmed-meshheading:11983232-Leukocytes, Mononuclear,
pubmed-meshheading:11983232-Polymerase Chain Reaction,
pubmed-meshheading:11983232-Proteins,
pubmed-meshheading:11983232-RNA, Messenger
|
pubmed:year |
2002
|
pubmed:articleTitle |
Evaluation of IFNalpha bioavailability by MxA mRNA in HCV patients.
|
pubmed:affiliation |
Centro Sclerosi Multipla and Laboratorio di Neurobiologia Clinica, Divisione Universitaria di Neurologia, Azienda Ospedaliera S. Luigi, Università di Torino, Regione Gonzole 10, 10043 Orbassano, Italy. NSGLB@TIN.IT
|
pubmed:publicationType |
Journal Article
|